United States Antimony (UAMY) director granted RSUs and options on 08/19/2025
Rhea-AI Filing Summary
John M. Keane, a director of United States Antimony Corp (UAMY), filed an Initial Statement of Beneficial Ownership reporting no currently owned common shares and two time‑based awards granted on 08/19/2025. The filing shows 68,200 restricted stock units (RSUs) and a stock option covering 34,100 shares, each vesting one‑third on 08/19/2026, 08/19/2027, and 08/19/2028$4.26 and an expiration date of 08/19/2035. The RSUs convert to common stock at vesting; no direct common shares were reported.
Positive
- Substantial equity award granted: 68,200 RSUs and 34,100 options, aligning director incentives with shareholders
- Clear vesting schedule: one‑third vests annually on 08/19/2026, 08/19/2027, and 08/19/2028, supporting retention
Negative
- No currently owned common shares were reported, so there is no immediate direct share ownership
- Economic value of options depends on future stock price; strike is $4.26, so upside is not guaranteed
Insights
Director granted time‑based equity aligned with service through 2028.
The reported awards are standard director compensation: 68,200 RSUs and a stock option for 34,100 shares granted on 08/19/2025, both vesting in three equal annual tranches through 08/19/2028. The option expires on 08/19/2035 with a $4.26 exercise price, showing a long exercise window common for incentive awards.
These awards increase potential insider alignment with shareholder outcomes if the share price appreciates, but their full economic value depends on future vesting and stock performance; monitor vesting dates in 2026–2028 for realized changes in ownership.
Equity package mixes RSUs and options to balance retention and upside.
The RSU portion converts to common stock upon vesting, delivering guaranteed shares if service conditions are met, while the option provides upside leverage above the $4.26 strike. Vesting in three equal annual tranches is a typical retention structure for senior directors.
Key near‑term milestones are the first tranche vesting on 08/19/2026 and subsequent tranches each year through 08/19/2028; these dates will determine when insider ownership and potential voting power change.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on August 19, 2025 under the Issuer's Amended and Restated 2023 Equity Incentive Plan. One-third, or 22,733 shares of the 68,200 total number of shares, of the RSU award will vest on August 19, 2026 and an additional one-third of the total number of shares will vest on August 19, 2027 and August 19, 2028 subject to the Reporting Person's continued service through each vesting date.
- F2. Represents shares of Common Stock underlying a time-based vesting stock option award granted on August 19, 2025 under the Issuer's Amended and Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 11,367 shares of the 34,100 total number of shares on August 19, 2026 and an additional one-third of the total number of shares will vest on August 19, 2027 and August 19, 2028, subject to the Reporting Person's continued service through any vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
